JP2014510037A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014510037A5 JP2014510037A5 JP2013549896A JP2013549896A JP2014510037A5 JP 2014510037 A5 JP2014510037 A5 JP 2014510037A5 JP 2013549896 A JP2013549896 A JP 2013549896A JP 2013549896 A JP2013549896 A JP 2013549896A JP 2014510037 A5 JP2014510037 A5 JP 2014510037A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- ring
- aryl
- heteroaryl
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN184/MUM/2011 | 2011-01-21 | ||
| IN184MU2011 | 2011-01-21 | ||
| PCT/GB2012/050132 WO2012098416A1 (en) | 2011-01-21 | 2012-01-23 | Diarylacetylene hydrazide containing tyrosine kinase inhibitors |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014510037A JP2014510037A (ja) | 2014-04-24 |
| JP2014510037A5 true JP2014510037A5 (enExample) | 2015-03-12 |
| JP5905028B2 JP5905028B2 (ja) | 2016-04-20 |
Family
ID=45540888
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013549896A Active JP5905028B2 (ja) | 2011-01-21 | 2012-01-23 | ジアリールアセチレンヒドラジドを含有するチロシンキナーゼ阻害剤 |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US9024021B2 (enExample) |
| EP (1) | EP2665709B1 (enExample) |
| JP (1) | JP5905028B2 (enExample) |
| KR (1) | KR101892574B1 (enExample) |
| CN (1) | CN103502217B (enExample) |
| AU (1) | AU2012208388C1 (enExample) |
| BR (1) | BR112013018212B1 (enExample) |
| CA (1) | CA2825367C (enExample) |
| EA (1) | EA024194B8 (enExample) |
| ES (1) | ES2608829T3 (enExample) |
| MX (1) | MX336051B (enExample) |
| WO (1) | WO2012098416A1 (enExample) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11351123B2 (en) | 2017-03-15 | 2022-06-07 | Sun Pharma Advanced Research Company Limited | Amorphous dispersion of 4-methyl-3-quinolin-3-ylethynyl-benzoic acid n'-(2-chloro-6-methyl-benzoyl) hydrazide |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2013166295A1 (en) | 2012-05-02 | 2013-11-07 | Georgetown University | Treating neural disease with tyrosine kinase inhibitors |
| CN103664787B (zh) * | 2012-09-17 | 2015-09-09 | 南京圣和药业股份有限公司 | 炔杂芳环化合物及其应用 |
| EP2818471A1 (en) * | 2013-06-27 | 2014-12-31 | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. | Nitrogen bicyclic compounds as inhibitors for Scyl1 and Grk5 |
| GB2518873A (en) * | 2013-10-03 | 2015-04-08 | Agency Science Tech & Res | Bicyclic alkyne derivatives and uses thereof |
| MX2016006325A (es) * | 2013-11-15 | 2016-12-02 | Wistar Inst | Inhibidores del antígeno nuclear 1 de epstein-barr, y su método de uso. |
| EP3294705B1 (en) | 2015-05-14 | 2021-07-21 | The Wistar Institute Of Anatomy And Biology | Ebna1 inhibitors and methods using same |
| US10150733B2 (en) * | 2015-05-18 | 2018-12-11 | Sun Pharma Advanced Research Company Ltd. | Amidoheteroaryl aroyl hydrazide ethynes |
| CN108884066B (zh) * | 2016-02-16 | 2021-08-24 | 韩国科学技术研究院 | 作为蛋白激酶抑制剂的2，3，5-取代的噻吩化合物 |
| WO2017208267A1 (en) | 2016-06-02 | 2017-12-07 | Sun Pharma Advanced Research Company Limited | Treatment for parkinson's disease |
| EA037697B1 (ru) * | 2016-06-02 | 2021-05-12 | Сан Фарма Адвансед Ресёрч Компани Лимитед | Лечение болезни паркинсона |
| MA47798A (fr) | 2017-03-15 | 2020-01-22 | Sun Pharma Advanced Res Co Ltd | Nouvelle dispersion amorphe d'acide cyclopropanecarboxylique (5-{5-[ n'-(2-chloro-6-méthylbenzoyl) hydrazinocarbonyl] -2-méthyl-phényléthynyl}-pyridin-2-yl) amide |
| WO2019222470A1 (en) | 2018-05-17 | 2019-11-21 | The Wistar Institute | Ebna1 inhibitor crystalline forms, and methods of preparing and using same |
| CN113272308B (zh) | 2018-11-20 | 2025-03-18 | 乔治敦大学 | 用于治疗神经退行性、肌退行性和溶酶体贮积病症的组合物和方法 |
| BR112021024835A2 (pt) | 2019-06-11 | 2022-01-18 | Sun Pharma Advanced Res Co Ltd | Tratamento para sinuclenopatias |
| MX2022007988A (es) | 2019-12-26 | 2022-07-11 | Beijing Innocare Pharma Tech Co Ltd | Formas cristalinas de (s)-1-(1-acriloilpirrolidin-3-il)-3-((3,5-di metoxifenil)etinil)-5-(metilamino)-1h-pirazol-4-carboxamida. |
| CN115279759B (zh) | 2020-02-28 | 2025-07-29 | 大邱庆北尖端医疗产业振兴财团 | 苯甲酰胺衍生物及其制备方法和用途 |
| IL300044A (en) | 2020-07-31 | 2023-03-01 | Sun Pharma Advanced Res Co Ltd | N'-(2-chloro-6-methylbenzoyl)-4-methyl-3-[2-(3-quinolyl) ethynyl]-benzohydrazide for treatment of alzheimer's disease |
| TW202317530A (zh) | 2021-06-29 | 2023-05-01 | 日商住友化學股份有限公司 | 雜環化合物及含有其之組成物之抗藥性有害節肢動物防除方法 |
| CN120018848A (zh) | 2022-08-25 | 2025-05-16 | 太阳医药高级研究有限公司 | 使用酪氨酸激酶抑制剂沃多巴替尼治疗慢性髓细胞白血病的方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5521184A (en) | 1992-04-03 | 1996-05-28 | Ciba-Geigy Corporation | Pyrimidine derivatives and processes for the preparation thereof |
| NZ513639A (en) | 1999-04-15 | 2004-02-27 | Bristol Myers Squibb Co | Cyclic protein tyrosine kinase inhibitors |
| MXPA02010231A (es) * | 2001-11-27 | 2004-12-13 | Warner Lambert Co | Inhibidores aminotransferasa dependientes de aminoacidos de cadena ramificada y su uso en el tratamiento de las enfermedades neurodegenerativas. |
| GB0215676D0 (en) | 2002-07-05 | 2002-08-14 | Novartis Ag | Organic compounds |
| ES2332184T3 (es) * | 2004-03-22 | 2010-01-28 | ELI LILLY & COMPANY | Derivados de piridilo y su uso como antagonistas del receptor mglu5. |
| SI1973545T1 (sl) * | 2005-12-23 | 2013-04-30 | Ariad Pharmaceuticals, Inc. | Spojine bicikličnega heteroarila |
| DK1973545T3 (da) * | 2005-12-23 | 2013-02-25 | Ariad Pharma Inc | Bicykliske heteroarylforbindelser |
| US7790756B2 (en) | 2006-10-11 | 2010-09-07 | Deciphera Pharmaceuticals, Llc | Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases |
| WO2009100536A1 (en) * | 2008-02-15 | 2009-08-20 | Methylgene Inc. | Inhibitors of kinase activity with 1,2-di-cyclyl substituted alkyne structures |
-
2012
- 2012-01-23 AU AU2012208388A patent/AU2012208388C1/en active Active
- 2012-01-23 EA EA201370166A patent/EA024194B8/ru unknown
- 2012-01-23 ES ES12701370.4T patent/ES2608829T3/es active Active
- 2012-01-23 JP JP2013549896A patent/JP5905028B2/ja active Active
- 2012-01-23 KR KR1020137021626A patent/KR101892574B1/ko active Active
- 2012-01-23 WO PCT/GB2012/050132 patent/WO2012098416A1/en not_active Ceased
- 2012-01-23 BR BR112013018212-1A patent/BR112013018212B1/pt active IP Right Grant
- 2012-01-23 US US13/980,108 patent/US9024021B2/en active Active
- 2012-01-23 EP EP12701370.4A patent/EP2665709B1/en active Active
- 2012-01-23 CN CN201280014166.8A patent/CN103502217B/zh active Active
- 2012-01-23 MX MX2013008296A patent/MX336051B/es unknown
- 2012-01-23 CA CA2825367A patent/CA2825367C/en active Active
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11351123B2 (en) | 2017-03-15 | 2022-06-07 | Sun Pharma Advanced Research Company Limited | Amorphous dispersion of 4-methyl-3-quinolin-3-ylethynyl-benzoic acid n'-(2-chloro-6-methyl-benzoyl) hydrazide |
| US12194153B2 (en) | 2017-03-15 | 2025-01-14 | Sun Pharma Advanced Research Company Limited | Amorphous dispersion of 4-methyl-3-quinolin-3-ylethynyl-benzoic acid n′-(2-chloro-6-methyl-benzoyl) hydrazide |